Abstract
BACKGROUND AND PURPOSE: Multidelay arterial spin-labeling is a promising emerging method in clinical practice. The effect of imaging parameters in multidelay arterial spin-labeling on estimated cerebral blood flow measurements remains unknown. We directly compared 3-delay versus 7-delay sequences, assessing the difference in the estimated transit time and blood flow.
MATERIALS AND METHODS: This study included 87 cognitively healthy controls (78.7 ± 3.8 years of age; 49 women). We assessed delay and transit time–uncorrected and transit time–corrected CBF maps. Data analysis included voxelwise permutation-based between-sequence comparisons of 3-delay versus 7-delay, within-sequence comparison of transit time–uncorrected versus transit time–corrected maps, and average CBF calculations in regions that have been shown to differ.
RESULTS: The 7-delay sequence estimated a higher CBF value than the 3-delay for the transit time–uncorrected and transit time–corrected maps in regions corresponding to the watershed areas (transit time–uncorrected = 27.62 ± 12.23 versus 24.58 ± 11.70 mL/min/100 g, Cohen's d = 0.25; transit time–corrected = 33.48 ± 14.92 versus 30.16 ± 14.32 mL/min/100 g, Cohen's d = 0.23). In the peripheral regions of the brain, the estimated delay was found to be longer for the 3-delay sequence (1.52408 ± 0.25236 seconds versus 1.47755 ± 0.24242 seconds, Cohen's d = 0.19), while the inverse was found in the center of the brain (1.39388 ± 0.22056 seconds versus 1.42565 ± 0.21872 seconds, Cohen's d = 0.14). Moreover, 7-delay had lower hemispheric asymmetry.
CONCLUSIONS: The results of this study support the necessity of standardizing acquisition parameters in multidelay arterial spin-labeling and identifying basic parameters as a confounding factor in CBF quantification studies. Our findings conclude that multidelay arterial spin-labeling sequences with a high number of delays estimate higher CBF values than those with a lower number of delays.
ABBREVIATIONS:
- ASL
- arterial spin-labeling
- d
- Cohen's d
- PLD
- postlabeling delay
Footnotes
Disclosures: Merel van der Thiel—RELATED: Grant: This work is supported by Swiss National Foundation grants SNF 3200B0-1161193 and SPUM 33CM30-124111 and an unrestricted grant from the Association Suisse pour la Recherche Alzheimer.* Michael X. Burke—UNRELATED: Employment: GE Healthcare, Comments: full-time employee. R. Marc Lebel—UNRELATED: Employment: GE Healthcare; Stock/Stock Options: GE Healthcare, Comments: R.M.L. is a shareholder in GE. *Money paid to institution.
This work was supported by Swiss National Foundation grants SNF 3200B0-1161193 and SPUM 33CM30-124111 and an unrestricted grant from the Association Suisse pour la Recherche Alzheimer.
- © 2018 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org